西:

Jinli Luo1, Ling Zhou1, Aru Sun2

  • 1Institute of Metabolic Diseases, Guang' Anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China; Graduate College, Beijing University of Chinese Medicine, Beijing, 100029, China.

PubMed
概括

草药药物显示出通过减少甲状腺抗体和改善症状来治疗哈西莫托甲状腺炎 (HT) 的前景. 需要进一步的高质量研究来证实这些关于草药疗效和安全的初步发现.